177
Participants
Start Date
January 31, 2005
Primary Completion Date
October 31, 2005
Study Completion Date
October 31, 2005
liraglutide
Novo Nordisk Investigational Site, København S
Novo Nordisk Investigational Site, Copenhagen
Novo Nordisk Investigational Site, Hvidovre
Novo Nordisk Investigational Site, Hellerup
Novo Nordisk Investigational Site, Køge
Novo Nordisk Investigational Site, Kolding
Novo Nordisk Investigational Site, Århus C
Novo Nordisk Investigational Site, Aalborg
Novo Nordisk Investigational Site, Narbonne
Novo Nordisk Investigational Site, Marseille
Novo Nordisk Investigational Site, La Rochelle
Novo Nordisk Investigational Site, Nîmes
Novo Nordisk Investigational Site, Pessac
Novo Nordisk Investigational Site, Montpellier
Novo Nordisk Investigational Site, Rennes
Novo Nordisk Investigational Site, Dax
Novo Nordisk Investigational Site, Nevers
Novo Nordisk Investigational Site, Vénissieux
Novo Nordisk Investigational Site, Bratislava
Novo Nordisk Investigational Site, Bratislava
Novo Nordisk Investigational Site, Šahy
Novo Nordisk Investigational Site, Banská Bystrica
Novo Nordisk Investigational Site, Lučenec
Novo Nordisk Investigational Site, Antibes
Novo Nordisk Investigational Site, Mougins
Novo Nordisk Investigational Site, 's-Hertogenbosch
Novo Nordisk Investigational Site, Amsterdam
Novo Nordisk Investigational Site, Apeldoorn
Novo Nordisk Investigational Site, Groningen
Novo Nordisk Investigational Site, Hengelo
Novo Nordisk Investigational Site, Sliedrecht
Novo Nordisk Investigational Site, The Hague
Novo Nordisk Investigational Site, Bratislava
Novo Nordisk Investigational Site, Bratislava
Novo Nordisk Investigational Site, Košice
Novo Nordisk Investigational Site, Košice
Novo Nordisk Investigational Site, Košice
Novo Nordisk Investigational Site, Prešov
Novo Nordisk Investigational Site, Žilina
Lead Sponsor
Novo Nordisk A/S
INDUSTRY